Search Login Register

Vigabatrin Summary

Description: An analogue of GAMMA-AMINOBUTYRIC ACID. It is an irreversible inhibitor of 4-AMINOBUTYRATE TRANSAMINASE, the enzyme responsible for the catabolism of GAMMA-AMINOBUTYRIC ACID. (From Martindale The Extra Pharmacopoeia, 31st ed)

Also Known As: Aventis Brand of Vigabatrin; Hoechst Brand of Vigabatrin; Sabril; Sabrilex; Yamanouchi Brand of Vigabatrin Show All >>

Networked: 856 relevant articles (130 outcomes, 194 trials/studies) for this Drug

Key Diseases for which Vigabatrin is Relevant

  1. Infantile Spasms (West Syndrome) : 52 outcomes 38 studies in 198 results
  2. Seizures (Seizure) : 49 outcomes 58 studies in 329 results
  3. Epilepsy (Aura) : 34 outcomes 69 studies in 298 results
  4. Tuberous Sclerosis (Bourneville's Disease) : 20 outcomes 7 studies in 60 results
  5. Partial Epilepsies (Epilepsy, Partial) : 8 outcomes 18 studies in 60 results
Show All >>

Drugs Related to Vigabatrin

  1. lamotrigine (Lamictal)
  2. Adrenocorticotropic Hormone (ACTH)
  3. gabapentin (Neurontin)
  4. Carbamazepine (Tegretol)
  5. gamma-Aminobutyric Acid (GABA)
  6. topiramate (Topamax)
  7. tiagabine (Gabitril)
  8. Anticonvulsants (Antiepileptic Drugs)
  9. felbamate (Felbatol)
  10. Valproic Acid (Valproate, Semisodium)
Show All >>

Therapies Related to Vigabatrin

  1. Vagus Nerve Stimulation
  2. Relaxation Therapy
  3. Psychology Biofeedback (Biofeedback)
  4. Ketogenic Diet
  5. Intravenous Infusions
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.